Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05247320 · ClinicalTrials.gov registry record
Prospective Evaluation Analysis and Kinetics Registry
A clinical trial, sponsored by University of Utah.
- Completed
- Registry status
- 167
- Enrollment target
NCT05247320: Completed study, sponsored by University of Utah.
NCT05247320 is a clinical trial that has completed, run by University of Utah. The registered enrollment target is 167 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05247320 has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- 167 participants
- Enrollment target
Study Summary
In a cohort of patients electively treated for atrial arrhythmia with IV sotalol (initiation or dose escalation), this study will describe patient characteristics, short-term safety and efficacy, electrocardiographic monitoring, and PK and PD parameters (in a subset) associated with IV dosing approach.
Primary Outcome
To describe the characteristics of patients receiving treatment for atrial arrhythmias with the IV formulation of Sotalol.
Interventions
- DRUG Sotalol Injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 167 participants |
| Start Date | 2022-02-04 |
| Est. Completion | 2023-08-30 |
What the finished NCT05247320 record still lists
NCT05247320 is an observational study that tracks outcomes without assigning an intervention. The registered 167 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Sotalol Injection is the first listed.
NCT05247320 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05247320 about?
NCT05247320 is a clinical study titled "Prospective Evaluation Analysis and Kinetics Registry". In a cohort of patients electively treated for atrial arrhythmia with IV sotalol (initiation or dose escalation), this study will describe patient characteristics, short-term safety and efficacy, electrocardiographic monitoring, and PK and PD parameters (in a subset) associated with IV dosing approa...
What is the current status of trial NCT05247320?
This trial is currently completed. The enrollment target is 167 participants. The study started on 2022-02-04. Estimated completion is 2023-08-30.
What interventions are being tested in trial NCT05247320?
The interventions under investigation include: Sotalol Injection (DRUG).
Who is sponsoring clinical trial NCT05247320?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04248283 · 167 participants · NA
Adjustable Continence Therapy (ACT) for the Treatment of Female SUI
- NCT04552509 · 167 participants · NA
TRUEBEAM Stereotactic Body Radiotherapy for Localized Prostate Cancer
- NCT05516277 · 167 participants · NA
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
- NCT02118922 · 168 participants
A Study to Test the Diagnostic Potential of Brillouin Microscopy for Corneal Ectasia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI